Exploring other Available Peptides with Traci Eliszewski

Synopsis

Traci Eliszewski is a board certified adult-gerontology NP graduating from Marquette University in 2017; she worked in inpatient medicine as both a Neurology NP and an inpatient Hospitalist before shifting her career focus to integrative, functional, and retentive Medicine therapies 3 years ago. She has completed courses through Institute for Functional Medicine (IFM) and American Academy of Anti-Aging Medicine (A4M) as well as SSRP. She currently works in an integrated medicine clinic in Madison, Wisconsin with her husband, Dr. Drew who also works in functional medicine and chiropractic. Traci’s current focus is on overall health optimization, longevity, and anti-aging by optimizing hormones, weight loss, thyroid, gut heath, peptide therapy, and regenerative medicine techniques.

This time we venture into the world of non-invasive peptide options as we take a closer look at the multifaceted benefits of tesofensine, from mood enhancement to weight management. The journey continues with accounts of sermorelin and tesamorelin’s effectiveness in reshaping bodies and sharpening minds, coupled with a discussion about our commitment to responsible patient care. We’re dissecting the nuances of integrating these novel treatments into patient regimes, understanding the delicate balance between remarkable results and the imperative of patient suitability.

Topics discussed in this episode include:

• How groundbreaking peptide therapies like 5-amino-1MQ and
  amlexanox aid in weight loss and focus.
• Why these compounds also combat histamine-related issues and
  their role in mitochondrial function.
• Strategies for dosing peptides to maximize health benefits
  while ensuring patient safety.
• Debates on mold toxicity testing and the use of visual
  contrast sensitivity tests and other analyses.
• The multifaceted benefits of tesofensine for mood
  enhancement and weight management.
• Why tesofensine should not be combined with other SSRIs or
  SNRIs.
• Success stories of improvements seen from sermorelin and tesamorelin.
• How low-dose naltrexone complements other treatments for
  conditions like autoimmune diseases.
• The synergy between low-dose naltrexone and semaglutide in
  addressing food addiction.
• Why methylene blue is gaining attention for cognitive
  enhancement and infection control.
• Concerns around methylene blue with vasodilation and its
  contraindication in G6PD deficiency.
• The importance of informed consent and patient education on
  treatment options.
• How low-dose leucine helps prevent muscle loss in various
  patient demographics.
• Upcoming discussions on hormone replacement controversies
  and their implications.
• Insights into the use of tesamorelin for targeting visceral
  fat and improving cognitive function in older adults.